Doing Good Tech Versus Doing Good With Tech

 The FDA is currently considering clinical trials for a drug that would delay aging. The idea of extending human longevity is a controversial one, with some arguing for immortality and others arguing that a lifespan into the mid-70s is perfectly adequate. So is the drug good or bad? As an investor in science and technology, this is a non-trivial question for me. Read More